Covid-19 vaccines: In the rush for regulatory approval, do we need more data?
Date
2021-05-18Journal
BMJPublisher
BMJ Publishing GroupType
Article
Metadata
Show full item recordDescription
Peter Doshi questions the rush to seek FDA approval for the COVID-19 vaccines currently being administered under the FDA's "Emergency Use Authorization"Identifier to cite or link to this item
http://hdl.handle.net/10713/15669ae974a485f413a2113503eed53cd6c53
10.1136/bmj.n1244